× We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click our cookies policy for information on how to change your cookie settings.


meta|Evidence - COVID-19

Live meta-analysis and evidence synthesis of therapies for COVID19

tutorial video
En     Fr

Our approach
     
Treament Trials
deathsclinical improvementdeath or ventilation
corticosteroids0---
remdesivir 3 0.65 [0.21; 2.01], 2 RCTs, I2=0%
inconclusive result
1.38 [0.98; 1.95], 2 RCTs, I2=30% demonstrated
inconclusive result
-
hydroxychloroquine 5 1.43 [0.49; 4.21], 2 RCTs, I2=0%
inconclusive result
--
convalescent plasma treatment 1 ---
interferon 2 ---
anti-interleukin-6 4 1.06 [0.40; 2.84], 2 RCTs, I2=0%
inconclusive result
1.15 [0.90; 1.47], 1 RCT, I2=0%
inconclusive result
0.56 [0.35; 0.89], 2 RCTs, I2=0% demonstrated
moderate degree of certainty
lopinavir/ritonavir 1 0.47 [0.01; 24.30], 1 RCT, I2=0%
inconclusive result
3.92 [1.66; 9.24], 1 RCT, I2=0%
moderate degree of certainty
-
anakinra 1 ---
colchicine 1 ---
anticoagulant0---
Vitamin D 1 ---

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N) and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

   

- About - Our approach - Credits Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons